Healthcare Sector Stocks
The Healthcare sector has a total of 1055 stocks, with a combined market cap of $9.08 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 48.97.
Market Cap
9.08T
Revenue
4.66T
Profits
185.42B
PE Ratio
48.97
Profit Margin
3.98%
Dividend Yield
0.39%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | 1.89% | 3,422,380 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 619.30B | -0.24% | 6,931,753 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 430.95B | -0.95% | 4,570,167 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 366.86B | -2.13% | 4,712,394 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 317.05B | 0.03% | 7,052,064 | 66.57B |
| 6 | NVS | Novartis AG | 292.81B | -0.15% | 1,045,448 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 247.26B | -0.27% | 2,353,907 | 61.37B |
| 8 | AMGN | Amgen Inc. | 218.87B | -0.73% | 2,609,055 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 214.46B | 0.38% | 1,719,407 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 200.17B | 3.23% | 13,121,024 | 50.34B |
| 11 | ABT | Abbott Laboratories | 186.81B | 2.13% | 9,801,625 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 162.40B | -0.68% | 9,235,052 | 30.46B |
| 13 | PFE | Pfizer Inc. | 149.33B | 1.51% | 51,074,468 | 63.70B |
| 14 | DHR | Danaher Corporation | 140.58B | 0.16% | 2,793,691 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 132.02B | -0.40% | 2,594,560 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 131.04B | 0.82% | 9,553,636 | 49.19B |
| 17 | SYK | Stryker Corporation | 129.43B | 0.12% | 1,803,188 | 25.84B |
| 18 | CVS | CVS Health Corporation | 123.06B | -2.93% | 10,583,035 | 412.65B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 122.68B | -0.17% | 1,015,131 | 12.59B |
| 20 | MDT | Medtronic plc | 109.98B | -0.08% | 4,976,344 | 36.36B |
| 21 | GSK | GSK plc | 104.39B | 1.38% | 2,506,645 | 44.05B |
| 22 | SNY | Sanofi | 102.59B | 0.26% | 4,147,027 | 55.89B |
| 23 | MCK | McKesson Corporation | 101.59B | -0.67% | 1,607,599 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 88.53B | -0.18% | 986,691 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 84.88B | 0.04% | 910,923 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 77.10B | 0.46% | 783,951 | 15.53B |
| 27 | CI | The Cigna Group | 72.73B | 1.76% | 2,978,329 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 71.45B | 3.27% | 21,398,973 | 21.00B |
| 29 | COR | Cencora, Inc. | 62.02B | 2.46% | 2,934,732 | 332.77B |
| 30 | CAH | Cardinal Health, Inc. | 55.66B | -0.66% | 1,796,518 | 250.74B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 54.68B | 1.79% | 4,272,051 | 28.42B |
| 32 | ARGX | argenx SE | 54.32B | 0.85% | 227,100 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 51.48B | 0.39% | 2,655,569 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 48.79B | 3.76% | 3,297,360 | 22.48B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 46.48B | 0.89% | 644,236 | 4.55B |
| 36 | MDLN | Medline Inc. | 45.37B | -5.89% | 14,525,293 | 29.94B |
| 37 | HUM | Humana Inc. | 44.10B | 0.94% | 1,371,687 | 145.68B |
| 38 | HLN | Haleon plc | 43.92B | 0.80% | 6,939,226 | 14.80B |
| 39 | RVMD | Revolution Medicines, Inc. | 42.05B | 0.26% | 1,747,582 | - |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 40.56B | 0.26% | 4,132,287 | 17.32B |
| 41 | A | Agilent Technologies, Inc. | 39.92B | 0.16% | 1,160,420 | 7.23B |
| 42 | WAT | Waters Corporation | 39.24B | -0.08% | 892,348 | 4.64B |
| 43 | IQV | IQVIA Holdings Inc. | 38.26B | -1.53% | 1,265,421 | 16.98B |
| 44 | NTRA | Natera, Inc. | 38.01B | -3.36% | 1,590,333 | 2.71B |
| 45 | ONC | BeOne Medicines AG | 37.50B | 0.69% | 279,839 | 6.13B |
| 46 | VEEV | Veeva Systems Inc. | 35.38B | 2.01% | 2,200,557 | 3.32B |
| 47 | ALC | Alcon Inc. | 33.86B | -1.46% | 1,858,984 | 10.63B |
| 48 | RPRX | Royalty Pharma plc | 32.92B | -0.85% | 2,441,510 | 2.54B |
| 49 | ZTS | Zoetis Inc. | 32.39B | 3.87% | 17,854,644 | 9.53B |
| 50 | RMD | ResMed Inc. | 32.20B | -0.35% | 1,786,086 | 5.65B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 31.76B | 0.10% | 4,351,164 | 21.27B |
| 52 | CNC | Centene Corporation | 31.71B | -4.16% | 5,471,429 | 180.30B |
| 53 | DXCM | DexCom, Inc. | 31.33B | 0.44% | 3,871,530 | 4.97B |
| 54 | BIIB | Biogen Inc. | 30.48B | -0.17% | 892,772 | 10.03B |
| 55 | ILMN | Illumina, Inc. | 29.25B | -3.08% | 4,276,170 | 4.49B |
| 56 | INSM | Insmed Incorporated | 28.93B | 33.86% | 12,036,146 | 1.14B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 28.92B | -5.51% | 2,274,559 | 4.80B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.48B | -0.02% | 126,970 | 4.13B |
| 59 | DGX | Quest Diagnostics Incorporated | 26.32B | 1.13% | 642,223 | 11.56B |
| 60 | PHG | Koninklijke Philips N.V. | 25.87B | -0.98% | 891,082 | 20.18B |
| 61 | LH | Labcorp Holdings Inc. | 25.67B | 0.82% | 440,063 | 14.35B |
| 62 | ROIV | Roivant Sciences Ltd. | 25.26B | 1.50% | 8,248,364 | 7.53M |
| 63 | WST | West Pharmaceutical Services, Inc. | 24.53B | -0.69% | 480,130 | 3.33B |
| 64 | INCY | Incyte Corporation | 24.00B | -1.19% | 2,390,460 | 5.82B |
| 65 | BNTX | BioNTech SE | 22.91B | -1.07% | 1,349,966 | 3.03B |
| 66 | UTHR | United Therapeutics Corporation | 22.86B | 2.68% | 998,775 | 3.15B |
| 67 | STE | STERIS plc | 22.59B | -0.40% | 1,383,810 | 6.04B |
| 68 | MRNA | Moderna, Inc. | 21.50B | -4.27% | 5,640,306 | 2.23B |
| 69 | GH | Guardant Health, Inc. | 21.15B | -3.43% | 1,513,666 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 20.66B | -1.95% | 725,643 | 21.81B |
| 71 | VTRS | Viatris Inc. | 18.97B | -7.71% | 21,024,435 | 14.74B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.54B | -0.99% | 2,998,253 | 8.51B |
| 73 | GMAB | Genmab A/S | 17.76B | 1.95% | 5,234,386 | 4.13B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 16.66B | -1.88% | 804,492 | 4.60B |
| 75 | ASND | Ascendis Pharma A/S | 16.47B | 2.31% | 746,643 | 998.25M |
| 76 | MEDP | Medpace Holdings, Inc. | 16.33B | -0.47% | 148,658 | 2.78B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 16.25B | -1.04% | 1,366,423 | 3.37B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 16.19B | 0.99% | 1,221,484 | 579.96M |
| 79 | COO | The Cooper Companies, Inc. | 14.30B | -2.03% | 1,932,134 | 4.23B |
| 80 | SOLV | Solventum Corporation | 14.12B | -5.16% | 2,355,161 | 8.31B |
| 81 | BAX | Baxter International Inc. | 13.96B | -1.17% | 6,944,710 | 11.47B |
| 82 | EXEL | Exelixis, Inc. | 13.12B | -7.94% | 5,410,948 | 2.44B |
| 83 | PEN | Penumbra, Inc. | 12.80B | 0.51% | 262,161 | 1.50B |
| 84 | FMS | Fresenius Medical Care AG | 12.79B | 0.88% | 882,113 | 22.19B |
| 85 | RVTY | Revvity, Inc. | 12.74B | -0.68% | 1,259,781 | 2.91B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.68B | -3.84% | 2,126,494 | 14.37B |
| 87 | CRL | Charles River Laboratories International, Inc. | 12.68B | 1.84% | 1,307,435 | 4.00B |
| 88 | ICLR | ICON Public Limited Company | 12.43B | -1.43% | 469,348 | 8.29B |
| 89 | SNN | Smith & Nephew plc | 12.43B | -1.46% | 1,195,819 | 6.30B |
| 90 | EHC | Encompass Health Corporation | 12.33B | 12.55% | 2,084,367 | 6.21B |
| 91 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.12B | -1.24% | 1,051,272 | 669.50M |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.09B | -7.70% | 17,210,880 | 5.02B |
| 93 | ALGN | Align Technology, Inc. | 12.01B | -3.29% | 655,763 | 4.14B |
| 94 | BMRN | BioMarin Pharmaceutical Inc. | 11.88B | 2.59% | 3,452,613 | 3.41B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.79B | -0.73% | 296,763 | 1.28B |
| 96 | CORT | Corcept Therapeutics Incorporated | 11.67B | -2.48% | 761,834 | 830.81M |
| 97 | DVA | DaVita Inc. | 11.52B | -4.25% | 1,819,143 | 14.01B |
| 98 | TECH | Bio-Techne Corporation | 11.20B | -0.14% | 2,314,987 | 1.21B |
| 99 | CYTK | Cytokinetics, Incorporated | 11.05B | 3.20% | 2,523,490 | 67.67M |
| 100 | GMED | Globus Medical, Inc. | 11.01B | 0.67% | 2,197,429 | 3.14B |
| 101 | ABVX | ABIVAX Société Anonyme | 10.95B | 3.68% | 1,076,013 | 5.67M |
| 102 | AXSM | Axsome Therapeutics, Inc. | 10.81B | -1.28% | 397,251 | 708.24M |
| 103 | SMMT | Summit Therapeutics Inc. | 10.80B | 0.07% | 2,487,267 | - |
| 104 | ENSG | The Ensign Group, Inc. | 10.50B | 1.68% | 318,441 | 5.49B |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 10.32B | 15.95% | 1,507,119 | 7.46M |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.27B | -0.25% | 2,566,458 | 3.50B |
| 107 | UHS | Universal Health Services, Inc. | 10.27B | -1.13% | 632,893 | 18.11B |
| 108 | HALO | Halozyme Therapeutics, Inc. | 10.17B | 2.60% | 2,704,018 | 1.66B |
| 109 | APGE | Apogee Therapeutics, Inc. | 10.10B | 0.19% | 1,232,939 | - |
| 110 | GKOS | Glaukos Corporation | 10.08B | 0.04% | 574,998 | 612.84M |
| 111 | MOH | Molina Healthcare, Inc. | 10.00B | -1.67% | 658,566 | 42.47B |
| 112 | HSIC | Henry Schein, Inc. | 9.83B | -1.52% | 1,155,153 | 13.60B |
| 113 | PODD | Insulet Corporation | 9.66B | 4.53% | 3,249,442 | 3.05B |
| 114 | KRYS | Krystal Biotech, Inc. | 9.55B | -0.95% | 206,286 | 440.48M |
| 115 | PTGX | Protagonist Therapeutics, Inc. | 9.40B | 6.45% | 837,631 | 281.99M |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 9.16B | -1.56% | 305,015 | 2.59B |
| 117 | SYRE | Spyre Therapeutics, Inc. | 9.12B | -0.89% | 454,483 | - |
| 118 | IONS | Ionis Pharmaceuticals, Inc. | 9.06B | 0.55% | 2,592,318 | 874.09M |
| 119 | RGEN | Repligen Corporation | 9.00B | 0.54% | 1,221,256 | 785.10M |
| 120 | AVTR | Avantor, Inc. | 8.91B | -1.35% | 8,735,340 | 6.56B |
| 121 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.90B | -0.10% | 2,096,262 | 42.16M |
| 122 | KYMR | Kymera Therapeutics, Inc. | 8.85B | 0.88% | 510,919 | 105.00M |
| 123 | HQY | HealthEquity, Inc. | 8.65B | -0.93% | 540,623 | 1.34B |
| 124 | ATR | AptarGroup, Inc. | 8.63B | -0.71% | 544,976 | 3.93B |
| 125 | QGEN | Qiagen N.V. | 8.63B | -0.52% | 4,028,166 | 2.10B |
| 126 | PCVX | Vaxcyte, Inc. | 8.50B | 5.31% | 1,284,490 | - |
| 127 | TEM | Tempus AI, Inc. | 8.32B | -1.24% | 2,569,829 | 1.43B |
| 128 | IMVT | Immunovant, Inc. | 8.20B | 1.17% | 917,990 | - |
| 129 | OSCR | Oscar Health, Inc. | 8.18B | -11.86% | 16,195,339 | 15.32B |
| 130 | ALKS | Alkermes plc | 8.11B | -2.50% | 1,569,089 | 1.67B |
| 131 | LQDA | Liquidia Corporation | 7.95B | 0.34% | 682,167 | 288.07M |
| 132 | BRKR | Bruker Corporation | 7.81B | -2.29% | 1,905,181 | 3.50B |
| 133 | IBRX | ImmunityBio, Inc. | 7.76B | 0.97% | 7,786,659 | 165.79M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.72B | 1.26% | 944,321 | 239.92M |
| 135 | PACS | PACS Group, Inc. | 7.39B | 2.26% | 1,092,116 | 5.55B |
| 136 | CHE | Chemed Corporation | 7.15B | 0.53% | 128,316 | 2.60B |
| 137 | COGT | Cogent Biosciences, Inc. | 7.14B | -1.11% | 1,043,364 | - |
| 138 | TGTX | TG Therapeutics, Inc. | 7.02B | -0.66% | 1,404,803 | 799.54M |
| 139 | GRFS | Grifols, S.A. | 6.95B | -1.26% | 362,333 | 8.48B |
| 140 | HIMS | Hims & Hers Health, Inc. | 6.87B | -6.29% | 8,294,482 | 2.37B |
| 141 | TWST | Twist Bioscience Corporation | 6.84B | -5.16% | 1,834,672 | 431.80M |
| 142 | CGON | CG Oncology, Inc. | 6.60B | 3.36% | 936,059 | 6.23M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.58B | -0.42% | 2,997,787 | 1.56B |
| 144 | ERAS | Erasca, Inc. | 6.34B | -1.88% | 2,427,103 | - |
| 145 | BLTE | Belite Bio, Inc | 6.32B | 1.37% | 133,417 | - |
| 146 | SRRK | Scholar Rock Holding Corporation | 6.31B | 9.96% | 1,617,162 | - |
| 147 | XENE | Xenon Pharmaceuticals Inc. | 6.24B | 0.39% | 435,010 | 7.50M |
| 148 | HNGE | Hinge Health, Inc. | 6.20B | -0.88% | 1,866,769 | 720.06M |
| 149 | TFX | Teleflex Incorporated | 6.15B | 1.54% | 1,328,636 | 2.25B |
| 150 | DNTH | Dianthus Therapeutics, Inc. | 6.15B | -2.29% | 708,374 | 1.90M |
| 151 | DFTX | Definium Therapeutics, Inc. | 6.12B | 3.94% | 1,782,246 | - |
| 152 | MIRM | Mirum Pharmaceuticals, Inc. | 6.11B | -11.04% | 2,969,294 | 618.07M |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.97B | -2.01% | 353,324 | 840.85M |
| 154 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | -0.80% | 393,774 | 290.54M |
| 155 | ORKA | Oruka Therapeutics, Inc. | 5.94B | 1.27% | 717,377 | - |
| 156 | PTCT | PTC Therapeutics, Inc. | 5.91B | 2.37% | 928,898 | 1.01B |
| 157 | TVTX | Travere Therapeutics, Inc. | 5.89B | -0.49% | 2,866,883 | 591.33M |
| 158 | BLCO | Bausch + Lomb Corporation | 5.84B | -2.45% | 328,646 | 5.32B |
| 159 | TXG | 10x Genomics, Inc. | 5.79B | -3.92% | 2,515,072 | 616.91M |
| 160 | AMRX | Amneal Pharmaceuticals, Inc. | 5.76B | -2.11% | 1,404,643 | 3.12B |
| 161 | CAI | Caris Life Sciences, Inc. | 5.65B | 21.58% | 11,272,924 | 989.61M |
| 162 | STVN | Stevanato Group S.p.A. | 5.54B | 0.95% | 386,408 | 1.40B |
| 163 | SHC | Sotera Health Company | 5.39B | 5.17% | 5,854,620 | 1.22B |
| 164 | RDNT | RadNet, Inc. | 5.36B | 1.64% | 611,923 | 2.14B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.24B | 0.58% | 1,288,891 | 1.58B |
| 166 | MMED | MiniMed Group, Inc. | 5.17B | -0.75% | 499,797 | 3.10B |
| 167 | CRSP | CRISPR Therapeutics AG | 4.99B | -1.54% | 1,025,535 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.90B | -1.22% | 3,049,755 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.83B | -1.11% | 1,330,688 | - |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.78B | -1.27% | 1,451,203 | - |
| 171 | INDV | Indivior Pharmaceuticals, Inc. | 4.56B | -0.15% | 2,676,315 | 1.33B |
| 172 | CELC | Celcuity Inc. | 4.55B | 0.36% | 569,613 | - |
| 173 | MANE | Veradermics, Incorporated | 4.54B | -2.42% | 457,094 | - |
| 174 | PBLS | Parabilis Medicines, Inc. | 4.53B | 1.95% | 263,716 | - |
| 175 | WAY | Waystar Holding Corp. | 4.48B | -0.04% | 3,794,750 | 1.21B |
| 176 | NVST | Envista Holdings Corporation | 4.40B | -4.37% | 6,024,262 | 2.86B |
| 177 | BLLN | BillionToOne, Inc. | 4.32B | -38.89% | 3,751,826 | 397.41M |
| 178 | RLAY | Relay Therapeutics, Inc. | 4.30B | 0.30% | 2,430,377 | 10.35M |
| 179 | ITGR | Integer Holdings Corporation | 4.29B | 0.86% | 1,823,145 | 1.84B |
| 180 | IRTC | iRhythm Holdings, Inc. | 4.21B | 2.91% | 1,206,112 | 825.34M |
| 181 | ELVN | Enliven Therapeutics, Inc. | 4.21B | 0.95% | 1,679,229 | - |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.19B | 0.73% | 1,317,575 | 56.99M |
| 183 | LIVN | LivaNova PLC | 4.17B | -3.03% | 932,462 | 1.47B |
| 184 | ICUI | ICU Medical, Inc. | 4.16B | -0.02% | 359,628 | 2.16B |
| 185 | LFST | LifeStance Health Group, Inc. | 4.07B | 2.80% | 9,143,149 | 1.58B |
| 186 | DNLI | Denali Therapeutics Inc. | 3.92B | 1.27% | 3,049,281 | 3.60M |
| 187 | CON | Concentra Group Holdings Parent, Inc. | 3.91B | -0.72% | 1,389,962 | 2.29B |
| 188 | VKTX | Viking Therapeutics, Inc. | 3.88B | -0.63% | 1,302,868 | - |
| 189 | HAE | Haemonetics Corporation | 3.86B | 1.70% | 1,275,251 | 1.35B |
| 190 | ADPT | Adaptive Biotechnologies Corporation | 3.77B | -4.07% | 2,466,113 | 308.08M |
| 191 | GPCR | Structure Therapeutics Inc. | 3.74B | 4.14% | 335,508 | - |
| 192 | LEGN | Legend Biotech Corporation | 3.73B | 1.21% | 2,072,955 | 1.14B |
| 193 | DOCS | Doximity, Inc. | 3.71B | -4.48% | 24,035,410 | 655.57M |
| 194 | VCYT | Veracyte, Inc. | 3.71B | - | 939,859 | 561.90M |
| 195 | TLX | Telix Pharmaceuticals Limited | 3.59B | 2.11% | 67,601 | 803.79M |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.56B | 2.27% | 2,696,714 | 117.00M |
| 197 | OGN | Organon & Co. | 3.56B | -0.15% | 1,879,458 | 6.13B |
| 198 | ALMS | Alumis Inc. | 3.54B | 2.51% | 653,458 | 8.40M |
| 199 | OPCH | Option Care Health, Inc. | 3.54B | -0.30% | 2,835,384 | 5.69B |
| 200 | IDYA | IDEAYA Biosciences, Inc. | 3.50B | 0.55% | 497,724 | 234.13M |
| 201 | BKD | Brookdale Senior Living Inc. | 3.43B | -0.49% | 2,767,799 | 3.00B |
| 202 | NHC | National HealthCare Corporation | 3.43B | -0.90% | 108,238 | 1.56B |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.32B | -2.47% | 3,264,376 | 463.98M |
| 204 | WRBY | Warby Parker Inc. | 3.31B | -7.89% | 6,027,098 | 911.61M |
| 205 | CLDX | Celldex Therapeutics, Inc. | 3.26B | 1.22% | 799,089 | 158.00K |
| 206 | NAMS | NewAmsterdam Pharma Company N.V. | 3.23B | 0.91% | 1,649,501 | 7.12M |
| 207 | MBX | MBX Biosciences, Inc. | 3.19B | -0.55% | 528,715 | - |
| 208 | QURE | uniQure N.V. | 3.15B | 2.53% | 1,268,112 | 18.67M |
| 209 | IRON | Disc Medicine, Inc. | 2.97B | -1.86% | 323,966 | - |
| 210 | IMNM | Immunome, Inc. | 2.92B | 1.18% | 860,150 | 4.02M |
| 211 | ACHC | Acadia Healthcare Company, Inc. | 2.86B | -4.71% | 1,601,095 | 3.37B |
| 212 | KOD | Kodiak Sciences Inc. | 2.83B | 4.10% | 638,888 | - |
| 213 | GRAL | GRAIL, Inc. | 2.83B | -14.53% | 1,882,132 | 165.26M |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 2.81B | 6.59% | 1,648,984 | 606.33M |
| 215 | TMDX | TransMedics Group, Inc. | 2.78B | 4.86% | 1,099,834 | 668.47M |
| 216 | ALHC | Alignment Healthcare, Inc. | 2.78B | -2.19% | 5,439,989 | 4.58B |
| 217 | IOVA | Iovance Biotherapeutics, Inc. | 2.77B | 43.09% | 73,430,649 | 324.97M |
| 218 | PRVA | Privia Health Group, Inc. | 2.77B | -8.18% | 4,409,698 | 2.36B |
| 219 | BEAM | Beam Therapeutics Inc. | 2.72B | 0.66% | 1,168,606 | 156.04M |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.72B | -0.32% | 1,344,879 | 830.44M |
| 221 | RGC | Regencell Bioscience Holdings Limited | 2.71B | -6.98% | 169,985 | - |
| 222 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.69B | 10.71% | 3,537,969 | -665.00K |
| 223 | ATAI | AtaiBeckley Inc. | 2.66B | -0.55% | 4,418,381 | 3.49M |
| 224 | PLSE | Pulse Biosciences, Inc. | 2.65B | 0.90% | 267,640 | 1.19M |
| 225 | XRAY | DENTSPLY SIRONA Inc. | 2.64B | -4.43% | 5,506,576 | 3.64B |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.63B | -0.80% | 1,961,067 | - |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.62B | 0.40% | 805,120 | 36.77M |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.58B | 2.74% | 837,704 | 1.10B |
| 229 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | 3.57% | 1,960,488 | 717.00M |
| 230 | GRDN | Guardian Pharmacy Services, Inc. | 2.50B | -2.54% | 283,183 | 1.46B |
| 231 | VRDN | Viridian Therapeutics, Inc. | 2.49B | 6.83% | 4,289,663 | 71.13M |
| 232 | NKTR | Nektar Therapeutics | 2.48B | 0.49% | 403,616 | 55.63M |
| 233 | PGEN | Precigen, Inc. | 2.47B | 0.29% | 7,269,948 | 85.72M |
| 234 | CLOV | Clover Health Investments, Corp. | 2.47B | 12.56% | 11,636,704 | 2.48B |
| 235 | NEOG | Neogen Corporation | 2.46B | -0.88% | 2,292,284 | 870.40M |
| 236 | KLRA | Kailera Therapeutics, Inc. | 2.44B | 3.85% | 178,332 | - |
| 237 | COAG | Hemab Therapeutics Holdings, Inc. | 2.44B | 4.13% | 278,765 | - |
| 238 | UFPT | UFP Technologies, Inc. | 2.41B | -3.16% | 215,131 | 631.64M |
| 239 | PHVS | Pharvaris N.V. | 2.41B | 3.08% | 570,609 | - |
| 240 | AXGN | Axogen, Inc. | 2.38B | -1.92% | 550,937 | 251.17M |
| 241 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | 0.52% | 443,422 | - |
| 242 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.38B | 2.54% | 4,044,212 | 940.61M |
| 243 | PGNY | Progyny, Inc. | 2.37B | -3.70% | 1,866,283 | 1.31B |
| 244 | ZLAB | Zai Lab Limited | 2.35B | 13.66% | 1,388,632 | 449.61M |
| 245 | HTFL | HeartFlow, Inc. | 2.34B | 0.07% | 471,028 | 191.42M |
| 246 | ESTA | Establishment Labs Holdings Inc. | 2.33B | -13.37% | 1,151,958 | 245.82M |
| 247 | CDNA | CareDx, Inc. | 2.32B | -1.52% | 790,067 | 458.09M |
| 248 | SLS | SELLAS Life Sciences Group, Inc. | 2.30B | -1.35% | 3,769,706 | - |
| 249 | VERA | Vera Therapeutics, Inc. | 2.30B | 5.50% | 1,943,721 | - |
| 250 | VCEL | Vericel Corporation | 2.29B | -1.34% | 334,657 | 306.30M |
| 251 | ADMA | ADMA Biologics, Inc. | 2.27B | 8.64% | 5,616,059 | 512.28M |
| 252 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 1.33% | 843,087 | 959.90M |
| 253 | SION | Sionna Therapeutics, Inc. | 2.24B | 4.80% | 778,470 | - |
| 254 | PVLA | Palvella Therapeutics, Inc. | 2.23B | 0.01% | 95,334 | - |
| 255 | URGN | UroGen Pharma Ltd. | 2.23B | -1.79% | 1,217,001 | 188.73M |
| 256 | RAPP | Rapport Therapeutics, Inc. | 2.22B | 9.21% | 408,370 | 20.00M |
| 257 | BHC | Bausch Health Companies Inc. | 2.21B | -6.04% | 3,514,926 | 10.85B |
| 258 | BFLY | Butterfly Network, Inc. | 2.21B | -1.43% | 4,721,899 | 112.14M |
| 259 | ADUS | Addus HomeCare Corporation | 2.17B | 1.99% | 218,096 | 1.48B |
| 260 | BHVN | Biohaven Ltd. | 2.17B | 5.80% | 1,881,364 | - |
| 261 | NUVB | Nuvation Bio Inc. | 2.13B | -4.08% | 8,394,941 | 169.90M |
| 262 | MD | Pediatrix Medical Group, Inc. | 2.10B | 2.00% | 1,065,212 | 1.95B |
| 263 | GHRS | GH Research PLC | 2.10B | 5.18% | 486,597 | - |
| 264 | WGS | GeneDx Holdings Corp. | 2.08B | -0.46% | 789,223 | 454.43M |
| 265 | AUPH | Aurinia Pharmaceuticals Inc. | 2.07B | 6.19% | 2,235,959 | 311.51M |
| 266 | STOK | Stoke Therapeutics, Inc. | 2.06B | - | 691,032 | 27.59M |
| 267 | HCM | HUTCHMED (China) Limited | 2.04B | 2.42% | 31,529 | 549.12M |
| 268 | MESO | Mesoblast Limited | 2.04B | 4.41% | 206,288 | 65.38M |
| 269 | ZBIO | Zenas BioPharma, Inc. | 2.03B | 0.97% | 676,927 | 10.00M |
| 270 | TSHA | Taysha Gene Therapies, Inc. | 2.03B | -1.86% | 2,106,289 | 7.47M |
| 271 | AVAH | Aveanna Healthcare Holdings Inc. | 2.03B | -0.21% | 1,283,298 | 2.52B |
| 272 | ATRC | AtriCure, Inc. | 2.01B | 0.38% | 762,180 | 569.62M |
| 273 | NEO | NeoGenomics, Inc. | 2.00B | -1.08% | 1,906,521 | 766.30M |
| 274 | ABCL | AbCellera Biologics Inc. | 1.99B | 10.30% | 8,412,137 | 66.17M |
| 275 | ALMR | Alamar Biosciences, Inc. | 1.95B | -0.88% | 246,415 | 87.16M |
| 276 | NBTX | Nanobiotix S.A. | 1.94B | -4.74% | 128,451 | 38.27M |
| 277 | SGRY | Surgery Partners, Inc. | 1.93B | -2.61% | 2,171,080 | 3.34B |
| 278 | OCUL | Ocular Therapeutix, Inc. | 1.92B | 2.82% | 1,594,002 | 52.06M |
| 279 | AGIO | Agios Pharmaceuticals, Inc. | 1.91B | 0.73% | 1,188,198 | 98.34M |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.88B | 1.33% | 380,673 | 367.34M |
| 281 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.29% | 1,725,221 | - |
| 282 | LMAT | LeMaitre Vascular, Inc. | 1.85B | 2.30% | 666,571 | 262.43M |
| 283 | DMRA | Damora Therapeutics, Inc. | 1.84B | -3.08% | 696,407 | - |
| 284 | BRVE | Braveheart Bio, Inc. | 1.84B | 65.56% | 3,292,187 | - |
| 285 | CMPS | COMPASS Pathways plc | 1.83B | -0.22% | 3,423,438 | - |
| 286 | NVCR | NovoCure Limited | 1.83B | -2.24% | 943,318 | 699.19M |
| 287 | KARD | Kardigan, Inc. | 1.82B | 0.54% | 249,165 | - |
| 288 | BCAX | Bicara Therapeutics Inc. | 1.81B | 6.26% | 704,024 | - |
| 289 | SEPN | Septerna, Inc. | 1.78B | 1.99% | 193,666 | 72.26M |
| 290 | GENB | Generate Biomedicines, Inc. | 1.78B | -4.14% | 842,947 | 26.48M |
| 291 | SRPT | Sarepta Therapeutics, Inc. | 1.77B | 5.34% | 5,241,392 | 1.97B |
| 292 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -0.80% | 1,476,631 | 252.25M |
| 293 | IMCR | Immunocore Holdings plc | 1.75B | 3.63% | 572,984 | 430.78M |
| 294 | ANIP | ANI Pharmaceuticals, Inc. | 1.75B | 3.44% | 717,205 | 923.71M |
| 295 | OBX | Obsidian Therapeutics, Inc. | 1.75B | -0.56% | 7,436 | - |
| 296 | PRGO | Perrigo Company plc | 1.74B | -5.50% | 4,266,690 | 4.14B |
| 297 | TRLV | Trulieve Cannabis Corp. | 1.73B | 6.64% | 891,756 | 1.17B |
| 298 | LKFT | Lakefront Biotherapeutics NV | 1.71B | 0.19% | 361,338 | 1.20B |
| 299 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | 0.32% | 14,794,378 | 54.86M |
| 300 | INSP | Inspire Medical Systems, Inc. | 1.70B | -2.00% | 681,944 | 898.74M |
| 301 | FTRE | Fortrea Holdings Inc. | 1.68B | -7.14% | 1,253,606 | 2.68B |
| 302 | BLFS | BioLife Solutions, Inc. | 1.66B | 0.38% | 461,486 | 106.69M |
| 303 | ZYME | Zymeworks Inc. | 1.66B | -1.57% | 673,710 | 37.13M |
| 304 | ARDT | Ardent Health, Inc. | 1.64B | 3.85% | 687,902 | 6.41B |
| 305 | OMCL | Omnicell, Inc. | 1.64B | -2.72% | 503,213 | 1.25B |
| 306 | ANAB | AnaptysBio, Inc. | 1.62B | -0.40% | 289,056 | 232.39M |
| 307 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.61B | -2.50% | 1,473,450 | 208.78M |
| 308 | TYRA | Tyra Biosciences, Inc. | 1.61B | 4.86% | 776,085 | - |
| 309 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | -3.49% | 443,837 | - |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.58B | 2.59% | 231,107 | 20.00M |
| 311 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 2.46% | 4,341,322 | 59.51M |
| 312 | AAPG | Ascentage Pharma Group International | 1.57B | 1.36% | 3,901 | 82.08M |
| 313 | INVA | Innoviva, Inc. | 1.56B | 2.93% | 1,311,036 | 440.00M |
| 314 | ASTH | Astrana Health, Inc. | 1.54B | -4.74% | 665,234 | 3.84B |
| 315 | ENOV | Enovis Corporation | 1.51B | -12.82% | 3,127,465 | 2.30B |
| 316 | HCSG | Healthcare Services Group, Inc. | 1.51B | -3.46% | 1,106,616 | 1.86B |
| 317 | CNMD | CONMED Corporation | 1.49B | 0.95% | 536,098 | 1.37B |
| 318 | INNV | InnovAge Holding Corp. | 1.49B | -0.99% | 146,278 | 949.17M |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.49B | 2.74% | 624,747 | - |
| 320 | HROW | Harrow, Inc. | 1.49B | 1.29% | 333,601 | 268.68M |
| 321 | XNCR | Xencor, Inc. | 1.49B | 0.81% | 996,659 | 104.97M |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.48B | 0.84% | 184,867 | 95.13M |
| 323 | VIR | Vir Biotechnology, Inc. | 1.48B | -3.79% | 2,602,609 | 303.23M |
| 324 | SVRA | Savara Inc. | 1.47B | 5.08% | 1,007,711 | - |
| 325 | AGL | agilon health, inc. | 1.46B | -19.49% | 921,579 | 5.92B |
| 326 | AVLN | Avalyn Pharma Inc. | 1.45B | 2.19% | 122,726 | - |
| 327 | AVBP | ArriVent BioPharma, Inc. | 1.44B | 1.31% | 181,581 | - |
| 328 | PAHC | Phibro Animal Health Corporation | 1.44B | -1.42% | 146,224 | 1.50B |
| 329 | ATEC | Alphatec Holdings, Inc. | 1.42B | -3.76% | 3,695,321 | 815.05M |
| 330 | ABSI | Absci Corporation | 1.41B | -1.19% | 1,769,956 | 1.84M |
| 331 | PSNL | Personalis, Inc. | 1.39B | -3.62% | 1,701,014 | 69.67M |
| 332 | LBRX | LB Pharmaceuticals Inc | 1.38B | 7.00% | 465,654 | - |
| 333 | PNTG | The Pennant Group, Inc. | 1.36B | 0.64% | 364,750 | 1.10B |
| 334 | ALVO | Alvotech | 1.36B | 1.06% | 503,349 | 562.04M |
| 335 | AZTA | Azenta, Inc. | 1.35B | -3.39% | 750,324 | 613.81M |
| 336 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | - | 887,666 | - |
| 337 | XERS | Xeris Biopharma Holdings, Inc. | 1.33B | -9.25% | 3,724,839 | 335.41M |
| 338 | SDGR | Schrödinger, Inc. | 1.33B | 8.60% | 2,740,419 | 259.04M |
| 339 | IART | Integra LifeSciences Holdings Corporation | 1.33B | -3.28% | 563,144 | 1.65B |
| 340 | GLUE | Monte Rosa Therapeutics, Inc. | 1.33B | 0.64% | 1,082,142 | 28.73M |
| 341 | JBIO | Jade Biosciences, Inc. | 1.32B | 2.49% | 1,112,753 | - |
| 342 | AKTS | Aktis Oncology, Inc. | 1.30B | 3.49% | 266,664 | 8.28M |
| 343 | AORT | Artivion, Inc. | 1.29B | 1.53% | 1,139,504 | 471.47M |
| 344 | TNDM | Tandem Diabetes Care, Inc. | 1.29B | -4.08% | 3,796,505 | 1.04B |
| 345 | IMTX | Immatics N.V. | 1.29B | -3.58% | 320,962 | 43.00M |
| 346 | VOR | Vor Biopharma Inc. | 1.28B | 6.42% | 735,455 | - |
| 347 | NVAX | Novavax, Inc. | 1.27B | 0.52% | 4,902,632 | 413.80M |
| 348 | ETON | Eton Pharmaceuticals, Inc. | 1.26B | 0.46% | 532,180 | 86.93M |
| 349 | GDRX | GoodRx Holdings, Inc. | 1.26B | 13.76% | 4,400,252 | 785.23M |
| 350 | INBX | Inhibrx Biosciences, Inc. | 1.26B | 2.26% | 87,655 | 1.30M |
| 351 | MNKD | MannKind Corporation | 1.25B | -5.12% | 9,306,198 | 393.63M |
| 352 | CERT | Certara, Inc. | 1.24B | 1.50% | 5,787,549 | 421.75M |
| 353 | SPTX | Seaport Therapeutics, Inc. | 1.24B | 3.36% | 106,562 | - |
| 354 | FRNM | Freenome, Inc. | 1.23B | - | 357,934 | 34.24M |
| 355 | TDOC | Teladoc Health, Inc. | 1.21B | -3.61% | 4,598,422 | 2.49B |
| 356 | ARDX | Ardelyx, Inc. | 1.20B | -0.81% | 7,283,061 | 450.89M |
| 357 | AMN | AMN Healthcare Services, Inc. | 1.19B | -6.10% | 1,276,752 | 3.43B |
| 358 | WVE | Wave Life Sciences Ltd. | 1.19B | 1.52% | 1,663,315 | 65.37M |
| 359 | MGTX | MeiraGTx Holdings plc | 1.18B | 1.91% | 354,384 | 79.76M |
| 360 | DRTS | Alpha Tau Medical Ltd. | 1.17B | -2.04% | 379,647 | - |
| 361 | BVS | Bioventus Inc. | 1.17B | -8.39% | 1,522,105 | 581.85M |
| 362 | IRMD | IRADIMED CORPORATION | 1.17B | -0.71% | 94,439 | 86.34M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 1.17B | -0.50% | 578,256 | - |
| 364 | OMDA | Omada Health, Inc. | 1.16B | 2.25% | 2,262,925 | 309.76M |
| 365 | STAA | STAAR Surgical Company | 1.15B | 1.14% | 725,570 | 290.38M |
| 366 | CRON | Cronos Group Inc. | 1.15B | 12.87% | 5,699,731 | 179.09M |
| 367 | USPH | U.S. Physical Therapy, Inc. | 1.14B | -1.61% | 450,250 | 804.27M |
| 368 | PRCT | PROCEPT BioRobotics Corporation | 1.14B | 3.57% | 2,302,076 | 337.34M |
| 369 | AHG | Akso Health Group | 1.13B | -9.59% | 7,578 | 13.83M |
| 370 | QDEL | QuidelOrtho Corporation | 1.11B | -6.74% | 2,749,632 | 2.67B |
| 371 | APMD | Apnimed, Inc. | 1.11B | 5.17% | 300,865 | 120.15M |
| 372 | ANRO | Alto Neuroscience, Inc. | 1.11B | 1.57% | 421,152 | - |
| 373 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | 1.93% | 595,357 | - |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 1.10B | 1.24% | 308,384 | 1.03B |
| 375 | IVA | Inventiva S.A. | 1.10B | -1.27% | 380,658 | 7.94M |
| 376 | REPL | Replimune Group, Inc. | 1.08B | 8.71% | 7,281,432 | - |
| 377 | EYPT | EyePoint, Inc. | 1.08B | 4.73% | 2,240,811 | 2.79M |
| 378 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.05B | -3.67% | 4,890,833 | 41.47M |
| 379 | NUTX | Nutex Health Inc. | 1.05B | -3.39% | 181,055 | 846.72M |
| 380 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | 3.16% | 123,153 | 99.00K |
| 381 | OLMA | Olema Pharmaceuticals, Inc. | 1.03B | 1.90% | 747,898 | - |
| 382 | SANA | Sana Biotechnology, Inc. | 1.02B | -2.85% | 1,830,598 | - |
| 383 | PCRX | Pacira BioSciences, Inc. | 1.02B | 2.85% | 820,079 | 746.16M |
| 384 | GERN | Geron Corporation | 1.01B | -3.68% | 16,207,172 | 204.56M |
| 385 | AVTX | Avalo Therapeutics, Inc. | 989.29M | -0.74% | 596,213 | 59.00K |
| 386 | OPK | OPKO Health, Inc. | 985.15M | -2.22% | 2,559,420 | 587.90M |
| 387 | JANX | Janux Therapeutics, Inc. | 981.85M | 0.63% | 540,892 | 24.00M |
| 388 | OMER | Omeros Corporation | 951.74M | 3.95% | 841,319 | 9.89M |
| 389 | GMRS | GMR Solutions Inc. | 945.75M | -0.49% | 232,975 | 5.83B |
| 390 | COLL | Collegium Pharmaceutical, Inc. | 944.15M | -18.55% | 2,132,049 | 808.21M |
| 391 | CSTL | Castle Biosciences, Inc. | 930.84M | 0.23% | 833,434 | 357.28M |
| 392 | ANNX | Annexon, Inc. | 917.52M | 4.28% | 3,049,251 | - |
| 393 | ABUS | Arbutus Biopharma Corporation | 896.82M | -1.73% | 1,265,755 | 191.45M |
| 394 | TBPH | Theravance Biopharma, Inc. | 876.93M | 0.12% | 272,441 | 109.78M |
| 395 | ATTO | Attovia Therapeutics, Inc. | 876.93M | -6.94% | 413,249 | 1.35M |
| 396 | AMPH | Amphastar Pharmaceuticals, Inc. | 873.48M | -2.12% | 527,334 | 730.02M |
| 397 | TALK | Talkspace, Inc. | 872.74M | -0.19% | 661,495 | 245.73M |
| 398 | INMD | InMode Ltd. | 869.11M | -0.59% | 498,722 | 374.63M |
| 399 | GLAS | Glass House Brands Inc. | 868.13M | 4.54% | 298,355 | 177.68M |
| 400 | DSGN | Design Therapeutics, Inc. | 861.75M | 1.47% | 353,680 | - |
| 401 | SLDB | Solid Biosciences Inc. | 857.50M | -0.23% | 577,466 | - |
| 402 | AURA | Aura Biosciences, Inc. | 851.51M | 7.52% | 577,514 | - |
| 403 | ACRS | Aclaris Therapeutics, Inc. | 850.55M | -4.25% | 2,821,807 | 8.22M |
| 404 | DBVT | DBV Technologies S.A. | 829.98M | -3.51% | 1,019,589 | 5.04M |
| 405 | SGP | SpyGlass Pharma, Inc. | 827.48M | 4.52% | 76,592 | - |
| 406 | KURA | Kura Oncology, Inc. | 823.83M | 0.87% | 844,100 | 71.64M |
| 407 | HSTM | HealthStream, Inc. | 821.53M | 0.39% | 286,480 | 321.12M |
| 408 | AVR | Anteris Technologies Global Corp. | 814.73M | 3.85% | 987,066 | 1.85M |
| 409 | SIBN | SI-BONE, Inc. | 813.01M | 0.55% | 435,022 | 213.60M |
| 410 | AHCO | AdaptHealth Corp. | 806.46M | -7.00% | 10,705,787 | 3.36B |
| 411 | MNPR | Monopar Therapeutics Inc. | 805.26M | 0.82% | 285,800 | - |
| 412 | CLYM | Climb Bio, Inc. | 801.65M | 12.27% | 1,425,533 | - |
| 413 | DRUG | Bright Minds Biosciences Inc. | 797.11M | 1.00% | 140,844 | - |
| 414 | CADL | Candel Therapeutics, Inc. | 775.20M | 1.15% | 1,298,232 | - |
| 415 | PHAR | Pharming Group N.V. | 771.24M | 1.59% | 3,735 | 366.48M |
| 416 | TENX | Tenax Therapeutics, Inc. | 762.42M | 1.99% | 1,191,903 | - |
| 417 | OCS | Oculis Holding AG | 747.60M | 2.57% | 264,919 | 1.40M |
| 418 | SSII | SS Innovations International, Inc. | 742.49M | -3.64% | 14,472 | 48.47M |
| 419 | CTMX | CytomX Therapeutics, Inc. | 733.66M | 0.60% | 1,937,260 | 18.30M |
| 420 | RIGL | Rigel Pharmaceuticals, Inc. | 732.62M | -3.11% | 480,964 | 276.79M |
| 421 | IMMX | Immix Biopharma, Inc. | 716.17M | 5.45% | 1,220,483 | - |
| 422 | GYRE | Gyre Therapeutics, Inc. | 713.53M | 2.73% | 49,092 | 117.05M |
| 423 | NGNE | Neurogene Inc. | 709.40M | -1.06% | 94,292 | 925.00K |
| 424 | PHR | Phreesia, Inc. | 705.89M | -0.61% | 788,674 | 495.59M |
| 425 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 703.34M | -2.01% | 186,961 | - |
| 426 | CBIO | Crescent Biopharma, Inc. | 703.22M | 4.19% | 151,351 | 11.88M |
| 427 | EVO | Evotec SE | 702.97M | -1.52% | 66,781 | 859.03M |
| 428 | IRWD | Ironwood Pharmaceuticals, Inc. | 701.25M | 2.65% | 3,361,971 | 389.32M |
| 429 | RGNX | REGENXBIO Inc. | 696.01M | 7.43% | 1,769,214 | 174.48M |
| 430 | ZVRA | Zevra Therapeutics, Inc. | 693.06M | 12.82% | 2,493,871 | 136.07M |
| 431 | CBLL | CeriBell, Inc. | 692.45M | -0.22% | 176,135 | 95.07M |
| 432 | HELP | Cybin Inc. | 688.02M | 5.41% | 3,619,370 | - |
| 433 | ALLO | Allogene Therapeutics, Inc. | 679.95M | 1.03% | 3,170,439 | 22.00K |
| 434 | ACHV | Achieve Life Sciences, Inc. | 672.42M | -1.65% | 572,076 | - |
| 435 | PHAT | Phathom Pharmaceuticals, Inc. | 666.42M | 1.94% | 1,471,362 | 239.66M |
| 436 | AGMB | AgomAb Therapeutics NV | 664.85M | -5.73% | 38,634 | - |
| 437 | TCMD | Tactile Systems Technology, Inc. | 650.97M | -3.74% | 184,866 | 343.52M |
| 438 | BWAY | BrainsWay Ltd. | 638.93M | 4.26% | 120,574 | 56.22M |
| 439 | BBNX | Beta Bionics, Inc. | 634.80M | 1.44% | 590,198 | 119.01M |
| 440 | FTH | Faeth Therapeutics, Inc. | 631.06M | -0.45% | 205,731 | - |
| 441 | ANGO | AngioDynamics, Inc. | 624.53M | 0.47% | 357,422 | 320.17M |
| 442 | NVCT | Nuvectis Pharma, Inc. | 613.51M | -2.23% | 210,554 | - |
| 443 | MDXG | MiMedx Group, Inc. | 609.28M | 0.48% | 1,389,720 | 355.17M |
| 444 | MPLT | MapLight Therapeutics, Inc. | 602.19M | 2.79% | 476,984 | - |
| 445 | TLRY | Tilray Brands, Inc. | 602.13M | 0.34% | 3,949,856 | 915.45M |
| 446 | KIDS | OrthoPediatrics Corp. | 596.09M | 2.33% | 394,823 | 252.72M |
| 447 | CRMD | CorMedix Inc. | 589.17M | 1.35% | 702,375 | 400.05M |
| 448 | ALT | Altimmune, Inc. | 585.37M | -0.66% | 3,977,253 | 36.00K |
| 449 | CTNM | Contineum Therapeutics, Inc. | 577.48M | 0.52% | 227,503 | - |
| 450 | TECX | Tectonic Therapeutic, Inc. | 570.23M | 2.23% | 91,970 | - |
| 451 | SOPH | SOPHiA GENETICS SA | 569.51M | 6.19% | 430,669 | 86.17M |
| 452 | ARVN | Arvinas, Inc. | 567.55M | 3.33% | 2,580,579 | 316.70M |
| 453 | RLMD | Relmada Therapeutics, Inc. | 563.26M | -1.29% | 984,259 | - |
| 454 | ARTV | Artiva Biotherapeutics, Inc. | 562.65M | -0.09% | 321,639 | 251.00K |
| 455 | DNA | Ginkgo Bioworks Holdings, Inc. | 555.26M | -9.28% | 1,734,515 | 132.42M |
| 456 | ANL | Adlai Nortye Ltd. | 553.60M | 5.89% | 316,672 | 5.00M |
| 457 | SLN | Silence Therapeutics plc | 553.58M | 4.27% | 252,800 | 839.00K |
| 458 | FDMT | 4D Molecular Therapeutics, Inc. | 551.51M | 2.63% | 297,342 | 88.24M |
| 459 | SPRY | ARS Pharmaceuticals, Inc. | 551.13M | 3.54% | 1,264,568 | 98.99M |
| 460 | STTK | Shattuck Labs, Inc. | 549.03M | -2.85% | 772,343 | 1.00M |
| 461 | ZURA | Zura Bio Limited | 542.44M | 1.24% | 569,750 | - |
| 462 | CTKB | Cytek Biosciences, Inc. | 540.73M | -0.48% | 1,425,716 | 206.71M |
| 463 | SGMT | Sagimet Biosciences Inc. | 539.71M | 1.16% | 1,465,728 | - |
| 464 | DCTH | Delcath Systems, Inc. | 534.05M | 22.49% | 2,986,658 | 95.42M |
| 465 | PRME | Prime Medicine, Inc. | 532.82M | -4.22% | 2,554,623 | 4.07M |
| 466 | AUTL | Autolus Therapeutics plc | 532.29M | 5.26% | 3,790,152 | 92.62M |
| 467 | WEAV | Weave Communications, Inc. | 529.91M | -2.06% | 1,273,707 | 257.79M |
| 468 | VSTM | Verastem, Inc. | 519.33M | 0.68% | 2,189,459 | 87.53M |
| 469 | VREX | Varex Imaging Corporation | 516.29M | -1.13% | 309,484 | 857.50M |
| 470 | FLGT | Fulgent Genetics, Inc. | 510.41M | 0.11% | 244,070 | 323.93M |
| 471 | ASMB | Assembly Biosciences, Inc. | 509.19M | -0.34% | 100,059 | 71.10M |
| 472 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 473 | BIOA | BioAge Labs, Inc. | 500.98M | 2.64% | 844,663 | 10.36M |
| 474 | STLN | Starling Oncology, Inc. | 498.91M | -0.80% | 2,020,641 | 587.24M |
| 475 | EIKN | Eikon Therapeutics, Inc. | 498.62M | -3.56% | 361,586 | - |
| 476 | PROK | ProKidney Corp. | 495.38M | -1.80% | 382,802 | 889.00K |
| 477 | OVID | Ovid Therapeutics Inc. | 494.60M | 1.15% | 1,294,432 | 7.12M |
| 478 | SRTA | Strata Critical Medical, Inc. | 494.53M | -4.44% | 1,189,237 | 255.98M |
| 479 | AQST | Aquestive Therapeutics, Inc. | 491.83M | 4.39% | 1,536,413 | 50.27M |
| 480 | RZLT | Rezolute, Inc. | 490.99M | 0.43% | 924,974 | - |
| 481 | EOLS | Evolus, Inc. | 489.43M | 19.90% | 2,919,903 | 316.49M |
| 482 | VALN | Valneva SE | 485.37M | -0.96% | 16,570 | 180.25M |
| 483 | QTTB | Q32 Bio Inc. | 482.18M | -1.76% | 604,514 | 53.74M |
| 484 | EVMN | Evommune, Inc. | 481.93M | 2.76% | 941,367 | 10.00M |
| 485 | SCTX | Scribe Therapeutics Inc. | 479.34M | 6.76% | 193,083 | 36.28M |
| 486 | NPCE | NeuroPace, Inc. | 473.90M | 1.46% | 286,857 | 99.53M |
| 487 | KYTX | Kyverna Therapeutics, Inc. | 471.16M | 1.44% | 505,260 | - |
| 488 | IKT | Inhibikase Therapeutics, Inc. | 470.97M | 0.42% | 422,921 | 1.00 |
| 489 | CERS | Cerus Corporation | 467.54M | 2.20% | 2,584,689 | 221.55M |
| 490 | SI | Shoulder Innovations, Inc. | 465.16M | -0.75% | 40,406 | 60.06M |
| 491 | PRLD | Prelude Therapeutics Incorporated | 464.15M | 3.08% | 242,342 | 16.72M |
| 492 | CTEV | Claritev Corporation | 457.56M | 2.72% | 80,703 | 978.76M |
| 493 | BNTC | Benitec Biopharma Inc. | 451.07M | 3.47% | 82,868 | - |
| 494 | CABA | Cabaletta Bio, Inc. | 450.03M | 1.85% | 2,742,287 | - |
| 495 | PRTA | Prothena Corporation plc | 449.19M | 1.06% | 418,686 | 54.53M |
| 496 | EDIT | Editas Medicine, Inc. | 445.04M | 5.45% | 3,429,394 | 47.01M |
| 497 | SLBT | SL Science Holding Limited | 441.24M | -2.50% | 35,695 | 3.27M |
| 498 | LRMR | Larimar Therapeutics, Inc. | 438.41M | 2.44% | 759,755 | - |
| 499 | EPRX | Eupraxia Pharmaceuticals Inc. | 434.34M | 2.78% | 199,720 | - |
| 500 | OFIX | Orthofix Medical Inc. | 431.77M | 1.73% | 624,016 | 833.19M |